MyAverix Finance
PA · Healthcare
DBV Technologies S.A. (DBV)
Biotechnology
DBV Technologies S.A. (DBV) is listed on PA in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $942.01M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DBV
DBV Technologies S.A. (DBV) — FAQ
What is DBV Technologies S.A.'s market cap?
DBV Technologies S.A. (DBV) has a reported market cap of $942.01M (data as of 2026-05-24).
What is DBV's P/E ratio?
The price-to-earnings (P/E) ratio for DBV Technologies S.A. (DBV) is 25.00 (data as of 2026-05-24).
Does DBV Technologies S.A. pay a dividend?
Dividend yield is not available in the current snapshot for DBV Technologies S.A. (DBV). Check the MyAverix Finance app for the latest dividend data.
What sector is DBV Technologies S.A. in?
DBV Technologies S.A. (DBV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is DBV listed on?
DBV is listed on PA.
What is DBV Technologies S.A.'s net margin?
DBV Technologies S.A. (DBV) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.